DRKS00029154已完成未知
Effect of Theophylline on ADCY5 Activation - From Cellular Studies to Improved Therapeutic Options for ADCY5-Related Dyskinesia Patients - TheoAD5
niversitätsklinikum Leipzig0 个研究点目标入组 1 人开始时间: 2022年6月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 2 Years 至 60 Years（—）
- 性别
- All
入选标准
- •ADCY5 mutation genetically proven
排除标准
- •Contraindicatins against theophylline treatment
研究者
相似试验
招募中
不适用
Evaluating theophylline efficacy in ADCY5-related disease Dyskinesia - a prospective studyG24.8Other dystoniaDRKS00034720Medizinische Fakultät Leipzig15
尚未招募
3 期
Investigating the effect of oral theophylline on complications caused by double JIRCT20190624043991N22Tehran University of Medical Sciences60
进行中（未招募）
1 期
Theophylline Effect in Acute Ischemic Stroke TrialAcute ischemic stroke patients eligible for standard intravenous recombinant tissue plasminogen activator (rtPA) thrombolytic therapy with magnet resonance imaging (MRI)-proved infarctionMedDRA version: 19.0Level: LLTClassification code 10023027Term: Ischaemic stroke NOSSystem Organ Class: 100000004852EUCTR2013-001989-42-DKBoris Modrau120
招募中
3 期
Evaluating the Therapeutic Effect of Theophylline and Zinc Sulfate Co-administration in Infertile Meinfertile men.Male infertilityIRCT20190714044209N1The University of Arak120
已完成
2 期
Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)Pseudohypoparathyroidism Type 1aAlbright Hereditary OsteodystrophyNCT02463409Vanderbilt University Medical Center6